Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia
· Delayed Price · Currency is SAR
22.80
0.00 (0.00%)
Apr 28, 2026, 6:07 PM AST
TADAWUL:9620 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 57 | 68 | 93 | - | - |
| Market Cap Growth | -38.38% | -26.32% | - | - | - |
| Enterprise Value | 48 | 52 | 89 | - | - |
| Last Close Price | 22.80 | 27.26 | 37.00 | - | - |
| PE Ratio | 28.97 | 34.64 | 19.35 | - | - |
| PS Ratio | 2.80 | 3.35 | 4.66 | - | - |
| PB Ratio | 1.85 | 2.21 | 3.20 | - | - |
| P/TBV Ratio | 1.85 | 2.21 | 3.20 | - | - |
| P/FCF Ratio | - | - | 17.55 | - | - |
| P/OCF Ratio | - | - | 16.87 | - | - |
| EV/Sales Ratio | 2.34 | 2.54 | 4.49 | - | - |
| EV/EBITDA Ratio | 12.94 | 15.11 | 14.75 | - | - |
| EV/EBIT Ratio | 19.05 | 20.68 | 17.43 | - | - |
| EV/FCF Ratio | -6.72 | - | 16.92 | - | - |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.06 | 0.13 | 0.36 |
| Debt / EBITDA Ratio | 0.41 | 0.41 | 0.29 | 0.35 | 0.51 |
| Debt / FCF Ratio | - | - | 0.34 | - | 0.58 |
| Net Debt / Equity Ratio | -0.30 | -0.30 | -0.57 | -0.12 | -0.42 |
| Net Debt / EBITDA Ratio | -2.72 | -2.72 | -2.72 | -0.34 | -0.67 |
| Net Debt / FCF Ratio | 1.32 | 1.32 | -3.12 | 1.01 | -0.69 |
| Asset Turnover | 0.59 | 0.59 | 0.77 | 1.08 | - |
| Inventory Turnover | 4.77 | 4.77 | 7.19 | 9.06 | - |
| Quick Ratio | 5.80 | 5.80 | 11.51 | 2.64 | 1.39 |
| Current Ratio | 10.26 | 10.26 | 12.94 | 3.81 | 1.69 |
| Return on Equity (ROE) | 6.58% | 6.58% | 22.08% | 38.27% | - |
| Return on Assets (ROA) | 4.54% | 4.54% | 12.31% | 16.18% | - |
| Return on Invested Capital (ROIC) | 9.28% | 11.75% | 38.61% | 50.28% | 84.94% |
| Return on Capital Employed (ROCE) | 7.40% | 7.40% | 16.20% | 25.40% | 35.50% |
| Earnings Yield | 3.45% | 2.89% | 5.17% | - | - |
| FCF Yield | -12.45% | -10.41% | 5.70% | - | - |
| Dividend Yield | - | - | 4.05% | - | - |
| Payout Ratio | - | - | 62.76% | 23.07% | - |
| Buyback Yield / Dilution | - | - | -69.42% | - | - |
| Total Shareholder Return | - | - | -65.37% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.